TY - JOUR ID - 2387 TI - Comparison of dexamethasone and Anti-D Immune globulin for immune thrombocytopenia purpura in children JO - Reviews in Clinical Medicine JA - RCM LA - en SN - 2345-6256 AU - Banihashem, Abdollah AU - Farhangi, Hamid AU - Mousavi Bazaz, Mojtaba AU - Badiee, Zahra AU - Ghasemi, Ali AU - Hesari, Sara AD - Department of Pediatrics, School of Medicine, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran AD - Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Y1 - 2014 PY - 2014 VL - 1 IS - 2 SP - 61 EP - 65 KW - Children KW - Dexamethasone KW - Immune thrombocytopenic purpura (ITP) DO - 10.17463/RCM.2014.02.005 N2 - Different therapeutic options in children with immune thrombocytopenic purpura include observation alone, periodic treatment with corticosteroids, intravenous immunoglobulin (IVIG) or anti-D, chronic administration of immunosuppressive agents, and splenectomy.Preference of the type of therapy depends on the degree of thrombocytopenia and clinical bleeding manifestations. Dexamethasone is safe but its side effects are the main disadvantages for its usage. Anti-D is more expensive than dexamethason but the side effect is rare and not dangerous and response to treatment is assessed in approximately 3 days after infusion. UR - https://rcm.mums.ac.ir/article_2387.html L1 - https://rcm.mums.ac.ir/article_2387_e0d59319714ee2554c7af6ab8abf169f.pdf ER -